Mario Bigioni
- Molecular Biology top 10%
- Oncology top 10%
- Physiology top 10%
- Cardiology and Cardiovascular Medicine top 10%
- Organic Chemistry top 10%
- Co-authors
- Carlo Alberto MaggiAntonino De LorenzoLaura Di RenzoMonica BinaschiM G PremrovCristina GosoStefano ManziniGiovanni Capranico
- Topics
- Cancer therapeutics and mechanisms (19 papers)Histone Deacetylase Inhibitors Research (7 papers)Protein Degradation and Inhibitors (6 papers)
- Partner nations
- ItalyUnited StatesSpain
In The Last Decade
Mario Bigioni
57 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 115
- Molecular Biology 796
- Oncology 376
- Physiology 301
- Cardiology and Cardiovascular Medicine 294
- Organic Chemistry 259
Countries citing papers authored by Mario Bigioni
This map shows the geographic impact of Mario Bigioni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mario Bigioni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mario Bigioni more than expected).
Fields of papers citing papers by Mario Bigioni
This network shows the impact of papers produced by Mario Bigioni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mario Bigioni. The network helps show where Mario Bigioni may publish in the future.
Co-authorship network of co-authors of Mario Bigioni
This figure shows the co-authorship network connecting the top 25 collaborators of Mario Bigioni. A scholar is included among the top collaborators of Mario Bigioni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mario Bigioni. Mario Bigioni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 2 | |
| 4 | 2 | |
| 5 | 129 | |
| 6 | 11 | |
| 7 | 5 | |
| 8 | 6 | |
| 9 | 19 | |
| 10 | 201 | |
| 11 | 17 | |
| 12 | 98 | |
| 13 | 12 | |
| 14 | 64 | |
| 15 | 25 | |
| 16 | 54 | |
| 17 | 4 | |
| 18 | 54 | |
| 19 | 24 | |
| 20 | 54 |
About Mario Bigioni
Mario Bigioni is a scholar working on Toxicology, Oncology and Molecular Biology, having authored 58 papers that have together received 1.8k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (19 papers), Histone Deacetylase Inhibitors Research (7 papers) and Protein Degradation and Inhibitors (6 papers). The work is most often cited by research in Toxicology (90 citations), Oncology (376 citations) and Cardiology and Cardiovascular Medicine (294 citations). Mario Bigioni has collaborated with scholars based in Italy, United States and Spain. Frequent co-authors include Carlo Alberto Maggi, Antonino De Lorenzo, Laura Di Renzo, Monica Binaschi, M G Premrov, Cristina Goso, Stefano Manzini, Giovanni Capranico, V. Del Gobbo and Fabio Galvano. Their work appears in journals such as Nucleic Acids Research, Journal of Clinical Oncology and American Journal of Clinical Nutrition.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.